Current gene therapy
CRISPR-Cas9: A Paradigm Shift in Gene Editing Addressing Antimicrobial Resistance.
Mahima Devi, Yashika, Shubhi Saxena, Sreyosi Guha Niyogi, Komal Kishor, Shubham Thakur
Published: 202610.2174/0115665232426265251126093935
Abstract
The development of traditional antibiotics has stalled due to an escalating antimicrobial resistance (AMR) crisis. Generating new antibiotic development paradigms is critically important. CRISPR-Cas9 gene-editing technology, originally derived from t…
Preview only. Read the full abstract at the source